查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1477966

3D 生物列印市場：依地區劃分的全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031 年

3D Bioprinting Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 發佈了全球 3D 生物列印市場的詳細分析，提供了 2024 年至 2031 年主要市場趨勢、成長驅動因素/課題以及新興趨勢的見解。本報告旨在為利害關係人提供詳細的數據和統計數據，以指導這一不斷發展的領域的策略決策。

全球3D生物列印市場預計將快速成長，2024年至2031年複合年增長率為15%。這一成長預計將使市場規模從 2024 年的估計 25 億美元擴大到 2031 年底的約 66 億美元。

重要見解

  • 預計市場價值（2024年）：25億美元
  • 預計市值（2031年）：66億美元
  • 全球市場成長率（2024-2031年複合年增長率）：15%

3D 生物列印市場 - 研究範圍：

3D 生物列印技術允許使用積層製造流程創建複雜的生物結構。它已成為組織工程、再生醫學和藥物研究的重要工具。技術的快速進步和對器官移植替代品不斷增長的需求正在推動該市場的成長。本報告的範圍涵蓋了 3D 生物列印的持續發展、其在各個領域的應用以及塑造該行業的廣泛趨勢。

市場驅動因素：

3D生物列印市場的快速成長是由多種因素推動的。隨著器官移植需求的不斷增長和供體器官的短缺，研究人員正在探索 3D 生物列印作為替代方案。材料和生物列印技術的進步使得複雜的組織結構的創建成為可能，擴大了再生醫學的潛力。此外，製藥業正在採用 3D 生物列印進行藥物測試和開發，從而實現更精確和更具成本效益的研究。此外，政府資助和學術研究正在促進創新和新產品開發，加速 3D 生物列印的採用。

市場限制因素：

儘管潛力巨大，3D 生物列印市場仍面臨初始成本高、技術複雜性和監管障礙等課題。該技術需要在設備、材料和專業知識方面進行大量投資，這對小型研究機構和公司來說可能是一個障礙。生物列印組織和器官的監管批准也是一個課題，必須滿足嚴格的安全和道德標準。此外，還必須解決有關生物相容性、可擴展性和可重複性的問題，以確保市場的持續成長。

市場機會：

3D生物列印市場存在許多創新和擴張的機會。新生物材料和生物列印技術的發展為創造更複雜和功能性的組織打開了大門。研究機構、大學和行業參與者之間的合作夥伴關係可以加速創新並推動市場成長。生物列印在製藥領域具有巨大潛力，因為它可以實現更準確的藥物測試和個人化醫療方法。此外，人們對再生醫學和器官移植等替代醫學的興趣日益濃厚，為公司開發新型生物列印應用創造了機會。

本報告解決的關鍵問題

  • 3D生物列印市場的預期複合年增長率是多少？
  • 推動生物3D列印市場成長的因素有哪些？
  • 哪個地區在3D生物列印市場中佔據最大的市場佔有率？
  • 誰是全球3D生物列印市場的主要參與者？
  • 3D生物列印市場的主要課題和商機是什麼？

目錄

第一章執行摘要

第二章市場概況

  • 市場範圍/分類
  • 市場定義/範圍/限制

第 3 章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章 關鍵成功因素

  • 產品採用/使用分析
  • 產品 USP/特點
  • 戰略推廣策略

第五章全球3D生物列印市場需求分析

  • 過去的市場規模（噸）分析，2019-2023
  • 2024-2031 年當前和未來市場量（噸）預測
  • 同比增長趨勢分析

第六章全球3D生物列印市場-價格分析

  • 依組成部分的區域價格分析
  • 全球平均價格分析基準

第七章全球3D生物列印市場需求（數量與規模）分析

  • 過去的市場（金額）分析，2019-2023
  • 當前和未來市場（價值）預測，2024-2031

第八章市場背景

  • 宏觀經濟因素
  • 預測變量 - 相關性和影響
  • 價值鏈
  • COVID-19 危機 - 影響評估
  • 市場動態

第 9 章全球 3D 生物列印市場分析：依組成部分

  • 簡介/主要發現
  • 過去的市場規模（金額）和數量分析，2019-2023
  • 目前和未來的市場規模（金額）和定量分析/預測，2024-2031
    • 3D生物打印機
    • 生物墨水
  • 依組件劃分的市場吸引力分析

第10章全球3D生物列印市場應用分析

  • 簡介/主要發現
  • 過去的市場規模（金額）和數量分析，2019-2023
  • 目前和未來的市場規模（金額）和定量分析/預測，2024-2031
    • 調查使用
    • 臨床應用
  • 依應用劃分的市場吸引力分析

第 11 章 全球 3D 生物列印市場分析：依最終使用者分類

  • 簡介/主要發現
  • 過去的市場規模（美國）和最終用戶數量分析，2019-2023
  • 依當前和未來市場規模（美國）和最終用戶在 2024-2031 年進行的數量分析和預測
    • 研究和學術機構
    • 生物製藥公司
    • 醫院
  • 最終用戶的市場吸引力分析

第 12 章 3D 生物列印市場分析：依地區

  • 介紹
  • 過去的市場規模（金額）和數量分析，2019-2023
  • 當前市場規模（金額）和數量分析/預測，2024-2031
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞和太平洋地區
    • 中東和非洲 (MEA)
  • 區域市場吸引力分析

第十三章北美3D生物列印市場分析

第14章拉丁美洲3D生物列印市場分析

第十五章歐洲3D生物列印市場分析

第十六章南亞和太平洋地區3D生物列印市場分析

第十七章東亞3D生物列印市場分析

第十八章中東與非洲3D生物列印市場分析

第十九章新興國家3D生物列印市場分析

  • 介紹
    • 主要國家市值佔比分析
    • 全球和國家成長比較
  • 美國3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 加拿大3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 墨西哥3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 巴西3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 德國3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 義大利3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 法國3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 英國3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 西班牙3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 比荷盧經濟聯盟3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 俄羅斯3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 中國3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 日本3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 韓國3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 印度3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 東協3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 澳洲和紐西蘭3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • GCC 國家 3D 生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 土耳其3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 北非3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶
  • 南非3D生物列印市場分析
    • 依類型
    • 依用途
    • 依最終用戶

第二十章市場結構分析

  • 依公司層級進行市場分析
  • 主要參與者的市場佔有率分析
  • 市場存在分析

第 21 章 競爭分析

  • 比賽儀表板
  • 競爭標桿
  • 衝突詳情
    • Envisiontec, Inc.
    • Precise Bio
    • Organovo Holdings, Inc.
    • Revotek Co., Ltd.
    • Inventia Life Science PTY LTD
    • Vivax Bio
    • Poietis
    • Allevi
    • Biomedical KK
    • Cellink Global
    • Bioprinting Solutions

第 22 章使用的假設和首字母縮略詞

第23章研究方法論

簡介目錄
Product Code: PMRREP3255

Persistence Market Research has released an in-depth analysis of the global 3D Bioprinting Market, providing insights into the key market dynamics, growth drivers, challenges, and emerging trends from 2024 through 2031. The report aims to equip stakeholders with detailed data and statistical information to guide strategic decision-making within this evolving sector.

The global 3D bioprinting market is expected to experience rapid growth, with a projected CAGR of 15% between 2024 and 2031. This growth is set to increase the market's value from an estimated USD 2.5 billion in 2024 to approximately USD 6.6 billion by the end of 2031.

Key Insights:

  • Estimated Market Value (2024): USD 2.5 Billion
  • Projected Market Value (2031): USD 6.6 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 15%

3D Bioprinting Market - Report Scope:

3D bioprinting technology allows for the creation of complex biological structures using additive manufacturing processes. It has emerged as a significant tool in tissue engineering, regenerative medicine, and pharmaceutical research. The rapid advancement in technology and the increasing demand for organ transplantation alternatives have driven the growth of this market. The scope of this report encompasses the ongoing developments in 3D bioprinting, its applications in various sectors, and the broader trends shaping the industry.

Market Growth Drivers:

The rapid growth in the 3D bioprinting market is driven by several factors. The growing need for organ transplantation and the shortage of donor organs are leading researchers to explore 3D bioprinting as an alternative. Advancements in materials and bioprinting techniques enable the creation of complex tissue structures, expanding the possibilities in regenerative medicine. Additionally, the pharmaceutical industry is adopting 3D bioprinting for drug testing and development, allowing for more precise and cost-effective research. Furthermore, government funding and academic research are contributing to technological innovation and new product development, accelerating the adoption of 3D bioprinting.

Market Restraints:

Despite the potential, the 3D bioprinting market faces challenges such as high initial costs, technical complexities, and regulatory hurdles. The technology requires significant investment in equipment, materials, and expertise, which can be a barrier for smaller research institutions and companies. Regulatory approval for bioprinted tissues and organs is another challenge, with strict safety and ethical standards to meet. Additionally, issues related to biocompatibility, scalability, and reproducibility must be addressed to ensure the market's sustained growth.

Market Opportunities:

The 3D bioprinting market presents numerous opportunities for innovation and expansion. The development of new biomaterials and bioprinting techniques opens doors for creating more complex and functional tissues. Collaborative partnerships between research institutions, universities, and industry players can accelerate innovation and drive market growth. The pharmaceutical sector offers significant potential, with bioprinting enabling more accurate drug testing and personalized medicine approaches. Furthermore, the increasing interest in regenerative medicine and organ transplantation alternatives creates opportunities for companies to develop novel bioprinting applications.

Key Questions Addressed in the Report:

  • What is the Expected Value CAGR of the 3D Bioprinting Market?
  • What are the Key Drivers Contributing to the Growth of the 3D Bioprinting Market?
  • Which Regions Hold the Largest Market Share in the 3D Bioprinting Market?
  • Who are the Key Players in the Global 3D Bioprinting Market?
  • What Are the Main Challenges and Opportunities in the 3D Bioprinting Market?

Competitive Landscape and Business Strategies:

Leading companies in the 3D bioprinting market, such as Organovo Holdings, Inc., 3D Systems, Inc., and CELLINK, focus on innovation, strategic partnerships, and product development to stay competitive. These companies invest heavily in research and development to improve bioprinting techniques and expand their product portfolios. Collaborations with academic institutions and pharmaceutical companies enable them to access new technologies and markets. Additionally, strategic acquisitions and partnerships with healthcare providers allow these companies to strengthen their market presence and broaden their customer base.

Key Companies Profiled:

  • Envisiontec, Inc.
  • Precise Bio
  • Organovo Holdings, Inc.
  • Revotek Co., Ltd.
  • Inventia Life Science PTY LTD
  • Vivax Bio
  • Poietis
  • Allevi
  • Biomedical K.K.
  • Cellink Global
  • Bioprinting Solutions

3D Bioprinting Market Segmentation:

By Component:

  • 3D Bioprinters
  • Bioinks

By Application:

  • Research Applications
  • Clinical Applications

By End User:

  • Research Organization and Academic Institutes
  • Biopharmaceutical Companies
  • Hospitals

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic Promotional Strategies

5. Global 3D Bioprinting Market Demand Analysis 2019-2023 and Forecast, 2024-2031

  • 5.1. Historical Market Volume (Tons) Analysis, 2019-2023
  • 5.2. Current and Future Market Volume (Tons) Projections, 2024-2031
  • 5.3. Y-o-Y Growth Trend Analysis

6. Global 3D Bioprinting Market - Pricing Analysis

  • 6.1. Regional Pricing Analysis By Component
  • 6.2. Global Average Pricing Analysis Benchmark

7. Global 3D Bioprinting Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Macro-Economic Factors
    • 8.1.1. Global GDP Growth Outlook
    • 8.1.2. Global Industry Value Added Overview
    • 8.1.3. Global Infrastructure Investment Overview
    • 8.1.4. Global Construction Spending Analysis
    • 8.1.5. Other Macro Economic Factors
  • 8.2. Forecast Factors - Relevance & Impact
    • 8.2.1. Top Companies Historical Growth
    • 8.2.2. GDP Growth forecast
    • 8.2.3. Construction Industry forecast
    • 8.2.4. End User Growth Outlook
    • 8.2.5. Collaboration Activities
  • 8.3. Value Chain
    • 8.3.1. Raw Material Suppliers
    • 8.3.2. List of Manufacturers
    • 8.3.3. List of Distributors
  • 8.4. COVID-19 Crisis - Impact Assessment
    • 8.4.1. Current Statistics
    • 8.4.2. Short-Mid-Long Term Outlook
    • 8.4.3. Likely Rebound
  • 8.5. Market Dynamics
    • 8.5.1. Drivers
    • 8.5.2. Restraints
    • 8.5.3. Opportunity Analysis
    • 8.5.4. Trends

9. Global 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031, by Component

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis by Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast by Component 2024-2031
    • 9.3.1. 3D Bioprinters
    • 9.3.2. Bioinks
  • 9.4. Market Attractiveness Analysis by Component

10. Global 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2024-2031
    • 10.3.1. Research Applications
    • 10.3.2. Clinical Applications
  • 10.4. Market Attractiveness Analysis By Application

11. Global 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) and Volume Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By End User 2024-2031
    • 11.3.1. Research Organization and Academic Institutes
    • 11.3.2. Biopharmaceutical Companies
    • 11.3.3. Hospitals
  • 11.4. Market Attractiveness Analysis By End User

12. Global 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume Analysis by Region, 2019-2023
  • 12.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast by Region, 2024-2031
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia and Pacific
    • 12.3.6. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 13.4.1. By Country
      • 13.4.1.1. U.S.
      • 13.4.1.2. Canada
    • 13.4.2. By Type
    • 13.4.3. By Application
    • 13.4.4. By End User
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Type
    • 13.5.3. By Application
    • 13.5.4. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Latin America 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 14.4.1. By Country
      • 14.4.1.1. Brazil
      • 14.4.1.2. Mexico
      • 14.4.1.3. Rest of Latin America
    • 14.4.2. By Type
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Type
    • 14.5.3. By Application
    • 14.5.4. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Europe 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 15.4.1. By Country
      • 15.4.1.1. Germany
      • 15.4.1.2. Italy
      • 15.4.1.3. France
      • 15.4.1.4. U.K.
      • 15.4.1.5. Spain
      • 15.4.1.6. BENELUX
      • 15.4.1.7. Russia
      • 15.4.1.8. Rest of Europe
    • 15.4.2. By Type
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Type
    • 15.5.3. By Application
    • 15.5.4. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. South Asia and Pacific 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 16.4.1. By Country
      • 16.4.1.1. India
      • 16.4.1.2. ASEAN
      • 16.4.1.3. Oceania
      • 16.4.1.4. Rest of South Asia & Pacific
    • 16.4.2. By Type
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Type
    • 16.5.3. By Application
    • 16.5.4. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. East Asia 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 17.4.1. By Country
      • 17.4.1.1. China
      • 17.4.1.2. Japan
      • 17.4.1.3. South Korea
    • 17.4.2. By Type
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Type
    • 17.5.3. By Application
    • 17.5.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa 3D Bioprinting Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis by Market Taxonomy, 2019-2023
  • 18.4. Market Size (US$ Mn) and Volume Forecast by Market Taxonomy, 2024-2031
    • 18.4.1. By Country
      • 18.4.1.1. GCC Countries
      • 18.4.1.2. Turkey
      • 18.4.1.3. Northern Africa
      • 18.4.1.4. South Africa
      • 18.4.1.5. Rest of Middle East and Africa
    • 18.4.2. By Type
    • 18.4.3. By Application
    • 18.4.4. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Type
    • 18.5.3. By Application
    • 18.5.4. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Emerging Countries 3D Bioprinting Market Analysis

  • 19.1. Introduction
    • 19.1.1. Market Value Proportion Analysis, By Key Countries
    • 19.1.2. Global Vs. Country Growth Comparison
  • 19.2. U.S. 3D Bioprinting Market Analysis
    • 19.2.1. By Type
    • 19.2.2. By Application
    • 19.2.3. By End User
  • 19.3. Canada 3D Bioprinting Market Analysis
    • 19.3.1. By Type
    • 19.3.2. By Application
    • 19.3.3. By End User
  • 19.4. Mexico 3D Bioprinting Market Analysis
    • 19.4.1. By Type
    • 19.4.2. By Application
    • 19.4.3. By End User
  • 19.5. Brazil 3D Bioprinting Market Analysis
    • 19.5.1. By Type
    • 19.5.2. By Application
    • 19.5.3. By End User
  • 19.6. Germany 3D Bioprinting Market Analysis
    • 19.6.1. By Type
    • 19.6.2. By Application
    • 19.6.3. By End User
  • 19.7. Italy 3D Bioprinting Market Analysis
    • 19.7.1. By Type
    • 19.7.2. By Application
    • 19.7.3. By End User
  • 19.8. France 3D Bioprinting Market Analysis
    • 19.8.1. By Type
    • 19.8.2. By Application
    • 19.8.3. By End User
  • 19.9. U.K. 3D Bioprinting Market Analysis
    • 19.9.1. By Type
    • 19.9.2. By Application
    • 19.9.3. By End User
  • 19.10. Spain 3D Bioprinting Market Analysis
    • 19.10.1. By Type
    • 19.10.2. By Application
    • 19.10.3. By End User
  • 19.11. BENELUX 3D Bioprinting Market Analysis
    • 19.11.1. By Type
    • 19.11.2. By Application
    • 19.11.3. By End User
  • 19.12. Russia 3D Bioprinting Market Analysis
    • 19.12.1. By Type
    • 19.12.2. By Application
    • 19.12.3. By End User
  • 19.13. China 3D Bioprinting Market Analysis
    • 19.13.1. By Type
    • 19.13.2. By Application
    • 19.13.3. By End User
  • 19.14. Japan 3D Bioprinting Market Analysis
    • 19.14.1. By Type
    • 19.14.2. By Application
    • 19.14.3. By End User
  • 19.15. S. Korea 3D Bioprinting Market Analysis
    • 19.15.1. By Type
    • 19.15.2. By Application
    • 19.15.3. By End User
  • 19.16. India 3D Bioprinting Market Analysis
    • 19.16.1. By Type
    • 19.16.2. By Application
    • 19.16.3. By End User
  • 19.17. ASEAN 3D Bioprinting Market Analysis
    • 19.17.1. By Type
    • 19.17.2. By Application
    • 19.17.3. By End User
  • 19.18. Australia and New Zealand 3D Bioprinting Market Analysis
    • 19.18.1. By Type
    • 19.18.2. By Application
    • 19.18.3. By End User
  • 19.19. GCC Countries 3D Bioprinting Market Analysis
    • 19.19.1. By Type
    • 19.19.2. By Application
    • 19.19.3. By End User
  • 19.20. Turkey 3D Bioprinting Market Analysis
    • 19.20.1. By Type
    • 19.20.2. By Application
    • 19.20.3. By End User
  • 19.21. Northern Africa 3D Bioprinting Market Analysis
    • 19.21.1. By Type
    • 19.21.2. By Application
    • 19.21.3. By End User
  • 19.22. South Africa 3D Bioprinting Market Analysis
    • 19.22.1. By Type
    • 19.22.2. By Application
    • 19.22.3. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies (Linear Alpha-Olefins)
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Envisiontec, Inc.
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.1.4. Sales Footprint
      • 21.3.1.5. Strategy Overview
    • 21.3.2. Precise Bio
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.2.4. Sales Footprint
      • 21.3.2.5. Strategy Overview
    • 21.3.3. Organovo Holdings, Inc.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.3.4. Sales Footprint
      • 21.3.3.5. Strategy Overview
    • 21.3.4. Revotek Co., Ltd.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.4.4. Sales Footprint
      • 21.3.4.5. Strategy Overview
    • 21.3.5. Inventia Life Science PTY LTD
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.5.4. Sales Footprint
      • 21.3.5.5. Strategy Overview
    • 21.3.6. Vivax Bio
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.6.4. Sales Footprint
      • 21.3.6.5. Strategy Overview
    • 21.3.7. Poietis
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.7.4. Sales Footprint
      • 21.3.7.5. Strategy Overview
    • 21.3.8. Allevi
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.8.4. Sales Footprint
      • 21.3.8.5. Strategy Overview
    • 21.3.9. Biomedical K.K.
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.9.4. Sales Footprint
      • 21.3.9.5. Strategy Overview
    • 21.3.10. Cellink Global
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.10.4. Sales Footprint
      • 21.3.10.5. Strategy Overview
    • 21.3.11. Bioprinting Solutions
      • 21.3.11.1. Overview
      • 21.3.11.2. Product Portfolio
      • 21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.11.4. Sales Footprint
      • 21.3.11.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology